Page last updated: 2024-12-07

oxymethacil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

oxymethacil: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID96369
SCHEMBL ID11507948
MeSH IDM0043960

Synonyms (29)

Synonym
nsc 70449
oxymetacil
2,4(1h,3h)-pyrimidinedione, 5-hydroxy-6-methyl-
5-hydroxy-6-methylpyrimidine-2,4(1h,3h)-dione
OPREA1_437114
EU-0066763
oxymethacil
nsc70449
nsc-70449
7417-28-9
5-hydroxy-6-methyl-1h-pyrimidine-2,4-dione
AKOS000541358
5-hydroxy-6-methyluracil
unii-qzd7suw02t
qzd7suw02t ,
STL371207
AKOS022633998
DTXSID40225139
SCHEMBL11507948
5-hydroxy-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
5-hydroxy-6-methyl-2,4(1h,3h)-pyrimidinedione
mfcd03807212
6-methylpyrimidine-2,4,5-triol
STL514192
isobarbituric acid, 6-methyl
5-hydroxy-6-methylpyrimidine-2,4-dione
oxymethyluracil
SB56826
CS-0322501
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's13 (81.25)18.2507
2000's2 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.12 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index5.52 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.57%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (96.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]